(Q43860851)

27 November 2017

title

Prognostic marker profiles for risk of distant metastases in colorectal cancer (English)

1 reference

27 November 2017

1 reference

J Neumann

1

1 reference

27 November 2017

S Reu

series ordinal

2

1 reference

27 November 2017

T Kirchner

series ordinal

3

1 reference

27 November 2017

language of work or name

German

0 references

publication date

1 February 2012

1 reference

27 November 2017

1 reference

27 November 2017

volume

33

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

39-44

1 reference

Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Classification of colorectal cancer based on correlation of clinical, morphological and molecular features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Role of the serrated pathway in colorectal cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Genetic prognostic and predictive markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Oncotype DX tumor gene expression profiling in stage II colon cancerApplication: Prognostic, risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Sporadic medullary carcinoma of the colon: a clinicopathologic comparison with nonhereditary poorly differentiated enteric-type adenocarcinoma and neuroendocrine colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1543-Y

A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer.

21 January 2018

1 reference

12 December 2020

Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation

1 reference

12 December 2020

Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms

1 reference

12 December 2020

[Development of molecular-pathologic entities of colorectal cancer]

1 reference

12 December 2020

Poor Survival Associated with theBRAFV600E Mutation in Microsatellite-Stable Colon Cancers

1 reference

12 December 2020

Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer

1 reference

12 December 2020

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors

1 reference

12 December 2020

10.1007/S00292-011-1543-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1013970474

0 references

1 reference